← Back to news
June 25, 2026
Medicare Launches Coverage for Obesity Drugs Amid Limited Public Awareness
- Starting July 1, eligible Medicare beneficiaries can access obesity drugs for a $50 monthly copay through the new Bridge program.
- A survey indicates 82% of older Americans are unaware of the new coverage, raising concerns about access and awareness.
- Enrollment in the Bridge program requires prior authorization and is not automatic, which may complicate access for some patients.
2 Sources
- Wegovy maker Novo Nordisk pushing for insurers to cover cost of weight loss jabsJun 25, 2026 at 11:12 AM · Independent
- Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yetJun 28, 2026 at 12:00 PM · CNBC